Hong Kong SAR

Shandong Weigao Group Medical Polymer Co is looking to spin off and list its orthopaedic business on Shanghai’s Nasdaq-style Star market.

China’s Simcere Pharmaceutical Group is seeking the green light to float on Hong Kong’s stock exchange after filing a listing application with the bourse.

Hong Kong-listed Link Real Estate Investment Trust has raised a HK$1bn ($129m) sustainability-linked loan from OCBC Bank.

Chinese property developer Yanlord Land Group has returned to the loan market with a dual-tranche refinancing deal of up to $1bn.

Hong Kong’s IPO market is gearing up for a busy few weeks as companies push for listing approvals before the end of June, with bankers and investors remaining bullish on the city’s stocks. Jonathan Breen reports.

Jiangxiaobai is planning to list in Hong Kong this year, according to a source close to the deal.

Chinese e-commerce company JD.com is set to raise HK$30.1bn ($3.87bn) from its Hong Kong secondary listing, according to a source familiar with the matter.

HSBC and Standard Chartered are facing a backlash from investors and politicians after publicly supporting China’s planned security law for Hong Kong.

There are many reasons to like Hong Kong, despite the goings-on in the city these days. I should know, having lived here for many decades.

Belle International is selling a block of shares in its sportswear subsidiary, Topsports International Holdings, according to a term sheet seen by GlobalCapital Asia.

Hong Kong’s renowned activist investor David Webb revealed this week that he has been diagnosed with cancer and will be taking a step back from his regular critiquing of governance and regulation in the city.

Everbright Water pulled a Rmb1.2bn ($170m) five year note on Tuesday, despite the leads extending bookbuilding and offering investors a juicier price.